Established and new treatment roadmaps for pleural mesothelioma: opinions of the Turkish Collaborative Group

Tarih

Yazarlar

Kaplan, Muhammet Ali

Sendur, Mehmet Ali Nahit

Cangir, Ayten Kayi

Kilickap, Saadettin

Ozdemir, Feyyaz

Ozyigit, Gokhan

DOI No

10.1016/j.currproblcancer.2023.101017

Diğer Tanımlayıcı No

WOS:001125100500001

Yayınevi

Anahtar kelimeler

Biomarker, Cancer, Chemotherapy, Immune checkpoint inhibitor, Immunotherapy, Pleural mesothelioma

URI

https://openaccess.acibadem.edu.tr/handle/11443/6092

Koleksiyonlar

Tam öğe sayfası